RECLAIM ALT-801-231

The RECLAIM study is a placebo-controlled trial designed to evaluate the efficacy and safety of Pemvidutide, a novel GLP-1/glucagon receptor dual agonist, in adults with AUD who are also overweight or obese.

Need additional information?

Please indicate if you heard about us by any of these means: